Dumont & Blake Investment Advisors LLC Cuts Stock Position in MetLife, Inc. (NYSE:MET)

Dumont & Blake Investment Advisors LLC lowered its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 3.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,650 shares of the financial services provider’s stock after selling 1,135 shares during the quarter. Dumont & Blake Investment Advisors LLC’s holdings in MetLife were worth $2,027,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. FWL Investment Management LLC bought a new position in shares of MetLife in the 4th quarter valued at about $26,000. DHJJ Financial Advisors Ltd. bought a new stake in shares of MetLife in the 3rd quarter valued at approximately $25,000. Studio Investment Management LLC purchased a new position in shares of MetLife in the 4th quarter worth approximately $29,000. Planned Solutions Inc. bought a new position in shares of MetLife during the 4th quarter valued at approximately $28,000. Finally, Eagle Bay Advisors LLC purchased a new stake in MetLife during the 2nd quarter valued at $28,000. 89.81% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MET has been the topic of a number of analyst reports. The Goldman Sachs Group upgraded shares of MetLife from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $70.00 to $80.00 in a research report on Monday, January 8th. UBS Group cut their price target on shares of MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a report on Monday, February 5th. Keefe, Bruyette & Woods decreased their price objective on shares of MetLife from $79.00 to $77.00 and set an “outperform” rating for the company in a research note on Thursday, December 7th. Finally, Wells Fargo & Company cut their target price on MetLife from $85.00 to $83.00 and set an “overweight” rating on the stock in a research note on Tuesday, February 6th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $77.23.

Check Out Our Latest Research Report on MET

MetLife Stock Up 0.5 %

Shares of NYSE MET traded up $0.33 during midday trading on Wednesday, reaching $73.56. 1,032,952 shares of the company’s stock traded hands, compared to its average volume of 3,687,112. The company has a market cap of $53.19 billion, a price-to-earnings ratio of 40.26, a P/E/G ratio of 0.55 and a beta of 1.04. The stock’s 50 day simple moving average is $70.27 and its 200-day simple moving average is $66.14. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.53. MetLife, Inc. has a one year low of $48.95 and a one year high of $74.39.

MetLife (NYSE:METGet Free Report) last announced its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.95 by ($0.02). The company had revenue of $18.72 billion for the quarter, compared to the consensus estimate of $18.07 billion. MetLife had a net margin of 2.36% and a return on equity of 19.48%. On average, analysts predict that MetLife, Inc. will post 8.81 EPS for the current fiscal year.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, March 14th. Shareholders of record on Tuesday, February 6th were issued a $0.52 dividend. The ex-dividend date was Monday, February 5th. This represents a $2.08 dividend on an annualized basis and a yield of 2.83%. MetLife’s dividend payout ratio is presently 113.66%.

Insider Buying and Selling at MetLife

In related news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the transaction, the insider now owns 146,981 shares in the company, valued at approximately $10,567,933.90. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the transaction, the insider now directly owns 146,981 shares in the company, valued at approximately $10,567,933.90. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the transaction, the executive vice president now directly owns 57,768 shares in the company, valued at $4,174,893.36. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.